FdaApplication
NDA 011751
Identifiers
- fda_app_no: NDA011751
Properties
| Property | Value |
|---|---|
| applicant_name | APOTHECON INC DIV BRISTOL MYERS SQUIBB |
| application_type | NDA |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PROLIXIN | FLUPHENAZINE HYDROCHLORIDE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| PROLIXIN | FLUPHENAZINE HYDROCHLORIDE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| PROLIXIN | FLUPHENAZINE HYDROCHLORIDE | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| PROLIXIN | FLUPHENAZINE HYDROCHLORIDE | 2.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| PROLIXIN | FLUPHENAZINE HYDROCHLORIDE | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
5 products